PEMETREXED DISODIUM

PEMETREXED DISODIUM was reported 39095 times

PEMETREXED DISODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOCELLULITIS 92 0.4299
1 EROSIVE PUSTULAR DERMATOSIS 21 0.4200
2 LUNG ADENOCARCINOMA RECURRENT 21 0.2039
3 MALIGNANT NEOPLASM OLIGOPROGRESSION 28 0.1407
4 SCLERODERMA-LIKE REACTION 22 0.1392
5 AUTOIMMUNE LUNG DISEASE 16 0.1356
6 EGFR GENE MUTATION 50 0.1337
7 IMMUNE-MEDIATED PNEUMONITIS 29 0.1239
8 LUNG ADENOCARCINOMA STAGE IV 45 0.1181
9 IMMUNE-MEDIATED LUNG DISEASE 200 0.1096
10 NON-SMALL CELL LUNG CANCER METASTATIC 88 0.1001
11 MELANODERMA 19 0.0990
12 NON-SMALL CELL LUNG CANCER RECURRENT 27 0.0954
13 NON-SMALL CELL LUNG CANCER 428 0.0893
14 IMMUNE-MEDIATED CHOLANGITIS 31 0.0864
15 IMMUNE-MEDIATED RENAL DISORDER 35 0.0845
16 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 19 0.0833
17 IMMUNE-MEDIATED DERMATITIS 84 0.0833
18 LUNG ADENOCARCINOMA METASTATIC 19 0.0815
19 FEBRILE BONE MARROW APLASIA 323 0.0759
20 IMMUNE-MEDIATED GASTRITIS 14 0.0729
21 AUTOIMMUNE NEPHRITIS 16 0.0727
22 ACQUIRED GENE MUTATION 95 0.0725
23 DERMO-HYPODERMITIS 43 0.0721
24 MALIGNANT TRANSFORMATION 32 0.0713
25 BRONCHIAL FISTULA 14 0.0693
26 IMMUNE-MEDIATED HYPOTHYROIDISM 78 0.0691
27 IMMUNE-MEDIATED ARTHRITIS 26 0.0682
28 HYPERCREATININAEMIA 34 0.0676
29 IMMUNE-MEDIATED HEPATIC DISORDER 129 0.0661
30 RADIATION OESOPHAGITIS 25 0.0656
31 THROMBOPHLEBITIS MIGRANS 22 0.0647
32 TUMOUR ASSOCIATED FEVER 26 0.0636
33 NON-SMALL CELL LUNG CANCER STAGE IV 23 0.0630
34 IMMUNE-MEDIATED HEPATITIS 128 0.0626
35 IMMUNE-MEDIATED ENTEROCOLITIS 230 0.0625
36 IMMUNE-MEDIATED NEPHRITIS 29 0.0618
37 LUNG ADENOCARCINOMA 179 0.0594
38 TUMOUR PSEUDOPROGRESSION 65 0.0594
39 IMMUNE-MEDIATED HYPERTHYROIDISM 15 0.0591
40 PERIPHERAL VEIN THROMBOSIS 14 0.0586
41 TUMOUR HYPERPROGRESSION 14 0.0565
42 PENILE ULCERATION 18 0.0550
43 PLEURAL MESOTHELIOMA MALIGNANT 17 0.0550
44 LICHENOID KERATOSIS 125 0.0547
45 METASTASES TO ADRENALS 49 0.0531
46 AUTOIMMUNE COLITIS 34 0.0527
47 IMMUNE-MEDIATED PANCREATITIS 20 0.0525
48 MYASTHENIC SYNDROME 38 0.0491
49 LYMPHANGIOSIS CARCINOMATOSA 51 0.0489
50 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 39 0.0489
51 SUPERIOR VENA CAVA SYNDROME 29 0.0480
52 IMMUNE-MEDIATED MYOCARDITIS 77 0.0476
53 PARANEOPLASTIC SYNDROME 31 0.0459
54 EPIDERMOLYSIS 21 0.0457
55 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 55 0.0441
56 METASTASES TO THE MEDIASTINUM 18 0.0437
57 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 38 0.0433
58 NEPHRITIS 143 0.0428
59 MALIGNANT PLEURAL EFFUSION 72 0.0427
60 RADIATION PNEUMONITIS 91 0.0425
61 APLASIA 81 0.0413
62 ACUTE INTERSTITIAL PNEUMONITIS 21 0.0402
63 BRONCHOSTENOSIS 22 0.0402
64 GLUCOCORTICOID DEFICIENCY 17 0.0402
65 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 71 0.0399
66 RADIATION NECROSIS 22 0.0384
67 IMMUNE-MEDIATED ADVERSE REACTION 58 0.0378
68 BRONCHOPLEURAL FISTULA 14 0.0372
69 RECALL PHENOMENON 31 0.0371
70 STASIS DERMATITIS 25 0.0365
71 HYPOPHYSITIS 73 0.0363
72 SKIN TOXICITY 203 0.0359
73 IMMUNE-MEDIATED HYPOPHYSITIS 16 0.0355
74 METASTASES TO PLEURA 37 0.0353
75 BICYTOPENIA 69 0.0352
76 HAEMATOTOXICITY 334 0.0351
77 METASTASES TO MENINGES 79 0.0347
78 IMMUNE-MEDIATED ENCEPHALITIS 18 0.0340
79 AORTITIS 23 0.0335
80 EXTREMITY NECROSIS 58 0.0332
81 PANCYTOPENIA 1830 0.0327
82 IMMUNE-MEDIATED THYROIDITIS 16 0.0324
83 SYSTEMIC SCLERODERMA 23 0.0316
84 PARONYCHIA 135 0.0307
85 HEPATIC CYTOLYSIS 391 0.0306
86 MALIGNANT NEOPLASM PROGRESSION 3139 0.0306
87 VISCERAL LEISHMANIASIS 22 0.0305
88 SECONDARY ADRENOCORTICAL INSUFFICIENCY 46 0.0304
89 RENAL TUBULAR NECROSIS 294 0.0299
90 NEUTROPENIC COLITIS 61 0.0295
91 HYPOPITUITARISM 51 0.0293
92 OESOPHAGITIS ULCERATIVE 20 0.0292
93 PNEUMONITIS 788 0.0289
94 THERAPY PARTIAL RESPONDER 450 0.0288
95 GENE MUTATION 57 0.0288
96 TUBULOINTERSTITIAL NEPHRITIS 534 0.0285
97 TRACHEO-OESOPHAGEAL FISTULA 18 0.0282
98 RENAL TUBULAR DISORDER 79 0.0281
99 HYPERAMYLASAEMIA 15 0.0275
100 PULMONARY ARTERY THROMBOSIS 21 0.0273
101 MYELOSUPPRESSION 958 0.0266
102 TUMOUR NECROSIS 28 0.0265
103 HYPERSENSITIVITY PNEUMONITIS 30 0.0263
104 NECROTISING MYOSITIS 22 0.0254
105 BONE MARROW TOXICITY 29 0.0245
106 GASTROINTESTINAL TOXICITY 117 0.0243
107 LUNG CANCER METASTATIC 69 0.0239
108 MUCOSAL INFLAMMATION 619 0.0236
109 NEPHROGENIC DIABETES INSIPIDUS 27 0.0234
110 OTOTOXICITY 43 0.0232
111 SMALL INTESTINAL PERFORATION 43 0.0229
112 METASTASES TO CENTRAL NERVOUS SYSTEM 290 0.0225
113 LYMPHADENOPATHY MEDIASTINAL 43 0.0224
114 HYPERTRANSAMINASAEMIA 156 0.0224
115 ADENOCARCINOMA 50 0.0223
116 BONE MARROW FAILURE 453 0.0223
117 ERYSIPELAS 111 0.0221
118 NEPHROPATHY TOXIC 240 0.0214
119 CARCINOEMBRYONIC ANTIGEN INCREASED 41 0.0211
120 NEUTROPENIC SEPSIS 151 0.0211
121 RADIOTHERAPY 40 0.0209
122 RENAL TUBULAR INJURY 25 0.0206
123 FULMINANT TYPE 1 DIABETES MELLITUS 21 0.0204
124 DUODENAL PERFORATION 20 0.0204
125 PHIMOSIS 15 0.0204
126 LYMPHANGITIS 16 0.0199
127 AORTIC THROMBOSIS 23 0.0199
128 PULMONARY TOXICITY 140 0.0198
129 PERFORMANCE STATUS DECREASED 91 0.0195
130 FEBRILE NEUTROPENIA 1285 0.0194
131 BRONCHIAL CARCINOMA 15 0.0190
132 SUPERINFECTION BACTERIAL 15 0.0189
133 INTERSTITIAL LUNG DISEASE 913 0.0188
134 GRANULOCYTE COUNT DECREASED 33 0.0178
135 DERMATITIS ACNEIFORM 107 0.0176
136 LUNG CONSOLIDATION 49 0.0175
137 ENTERITIS 111 0.0173
138 ANAL ULCER 14 0.0171
139 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 125 0.0166
140 EMBOLISM ARTERIAL 20 0.0166
141 NEOPLASM PROGRESSION 579 0.0166
142 SUPERFICIAL VEIN THROMBOSIS 14 0.0166
143 HYPOALBUMINAEMIA 128 0.0164
144 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 18 0.0164
145 LARGE INTESTINE INFECTION 20 0.0163
146 PERIPHERAL ISCHAEMIA 66 0.0161
147 MYOCARDITIS 184 0.0160
148 SMALL CELL LUNG CANCER 24 0.0159
149 PLEURAL FIBROSIS 16 0.0157
150 KIDNEY FIBROSIS 27 0.0156
151 HEPATOCELLULAR INJURY 219 0.0154
152 OCULAR TOXICITY 17 0.0154
153 HYPERTHYROIDISM 223 0.0154
154 OESOPHAGITIS 166 0.0152
155 EMBOLISM VENOUS 46 0.0152
156 ADRENAL DISORDER 29 0.0151
157 THROMBOCYTOPENIA 1675 0.0150
158 MIXED LIVER INJURY 45 0.0149
159 CANCER PAIN 38 0.0148
160 ENTEROCOLITIS 85 0.0147
161 CHOLANGITIS 91 0.0147
162 ADRENAL INSUFFICIENCY 178 0.0147
163 DIVERTICULAR PERFORATION 30 0.0146
164 SYSTEMIC INFECTION 24 0.0145
165 CAPILLARY LEAK SYNDROME 29 0.0140
166 GASTROINTESTINAL PERFORATION 58 0.0139
167 PALMAR ERYTHEMA 16 0.0139
168 RASH MACULO-PAPULAR 309 0.0139
169 CREATININE RENAL CLEARANCE DECREASED 54 0.0135
170 MAGNETIC RESONANCE IMAGING ABNORMAL 16 0.0134
171 NEUTROPHIL COUNT DECREASED 541 0.0133
172 COLITIS 502 0.0132
173 SUBCLAVIAN VEIN THROMBOSIS 15 0.0132
174 NEUTROPENIA 1792 0.0132
175 ASPARTATE AMINOTRANSFERASE ABNORMAL 20 0.0131
176 VENOUS THROMBOSIS 51 0.0130
177 PRERENAL FAILURE 18 0.0128
178 FEBRILE INFECTION 15 0.0127
179 DERMATITIS BULLOUS 92 0.0127
180 CHOLANGITIS SCLEROSING 26 0.0126
181 LEUKOPENIA 633 0.0126
182 TROPONIN T INCREASED 16 0.0126
183 NEPHROSCLEROSIS 14 0.0126
184 DRUG RESISTANCE 322 0.0125
185 MYOCARDIAL INJURY 14 0.0124
186 LARGE INTESTINE PERFORATION 86 0.0124
187 MESOTHELIOMA 16 0.0123
188 THYROIDITIS 37 0.0123
189 METASTASES TO PERITONEUM 31 0.0123
190 HEPATOTOXICITY 273 0.0122
191 AUTOIMMUNE HAEMOLYTIC ANAEMIA 42 0.0122
192 ENCEPHALITIS AUTOIMMUNE 16 0.0122
193 TUMOUR PAIN 16 0.0121
194 BRONCHIAL OBSTRUCTION 17 0.0121
195 DERMATITIS EXFOLIATIVE GENERALISED 42 0.0121
196 DISEASE PROGRESSION 1427 0.0120
197 VENA CAVA THROMBOSIS 20 0.0120
198 HYPOTHYROIDISM 384 0.0120
199 TOXIC SKIN ERUPTION 120 0.0119
200 ALANINE AMINOTRANSFERASE ABNORMAL 25 0.0118
201 CUTANEOUS LUPUS ERYTHEMATOSUS 23 0.0118
202 IMMUNE THROMBOCYTOPENIA 54 0.0118
203 DUODENITIS 36 0.0117
204 HAEMOPTYSIS 326 0.0117
205 HYPOTHALAMO-PITUITARY DISORDER 17 0.0117
206 HEPATITIS TOXIC 30 0.0115
207 MONOCYTE COUNT DECREASED 14 0.0115
208 PLEURAL EFFUSION 696 0.0114
209 ANAEMIA 2178 0.0114
210 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 16 0.0114
211 LUNG OPACITY 30 0.0114
212 HEPATITIS 291 0.0114
213 TOXIC EPIDERMAL NECROLYSIS 171 0.0112
214 IMMUNE-MEDIATED MYOSITIS 31 0.0112
215 DIABETES INSIPIDUS 27 0.0112
216 PURPURA 99 0.0112
217 KERATITIS 34 0.0112
218 VENOUS THROMBOSIS LIMB 23 0.0111
219 PULMONARY SEPSIS 16 0.0110
220 AUTOIMMUNE HEPATITIS 76 0.0109
221 BLOOD CHLORIDE DECREASED 28 0.0108
222 METASTASES TO LYMPH NODES 73 0.0108
223 HYPOMAGNESAEMIA 150 0.0108
224 PERIPHERAL MOTOR NEUROPATHY 15 0.0107
225 TYPE 1 DIABETES MELLITUS 64 0.0106
226 ORAL FUNGAL INFECTION 29 0.0106
227 METASTASES TO LUNG 122 0.0105
228 HYPOPROTEINAEMIA 20 0.0105
229 STAPHYLOCOCCUS TEST POSITIVE 22 0.0104
230 NON-CARDIAC CHEST PAIN 33 0.0104
231 METASTASES TO BONE 171 0.0104
232 PERIORBITAL OEDEMA 54 0.0104
233 ARTERIAL THROMBOSIS 20 0.0103
234 SPLENIC INFARCTION 18 0.0103
235 MULTIPLE-DRUG RESISTANCE 32 0.0103
236 CARDIAC TAMPONADE 49 0.0103
237 ANAEMIA MACROCYTIC 22 0.0103
238 ADRENOCORTICAL INSUFFICIENCY ACUTE 20 0.0102
239 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 39 0.0102
240 PERICARDIAL EFFUSION 236 0.0102
241 SEPTIC SHOCK 443 0.0102
242 HICCUPS 83 0.0101
243 ORGANISING PNEUMONIA 50 0.0101
244 PROTEINURIA 190 0.0100
245 ALVEOLITIS 14 0.0099
246 NEUTROPHIL COUNT ABNORMAL 28 0.0099
247 PNEUMOPERITONEUM 18 0.0097
248 ATELECTASIS 94 0.0097
249 THROMBOTIC THROMBOCYTOPENIC PURPURA 34 0.0096
250 PNEUMOTHORAX 153 0.0096
251 CYTOPENIA 118 0.0096
252 CHOLESTASIS 185 0.0096
253 GASTROINTESTINAL NECROSIS 28 0.0096
254 HYPOCALCAEMIA 181 0.0096
255 PANNICULITIS 23 0.0095
256 HYPERPYREXIA 40 0.0094
257 LEUKOENCEPHALOPATHY 35 0.0094
258 METASTASES TO LIVER 165 0.0094
259 METASTASIS 67 0.0094
260 HAEMOTHORAX 27 0.0093
261 HEPATITIS CHOLESTATIC 56 0.0093
262 PERIPHERAL SENSORY NEUROPATHY 54 0.0092
263 MYOSITIS 82 0.0091
264 EMBOLISM 75 0.0090
265 ESCHERICHIA BACTERAEMIA 21 0.0089
266 ISCHAEMIA 41 0.0089
267 DISSEMINATED INTRAVASCULAR COAGULATION 124 0.0088
268 POLYARTHRITIS 46 0.0087
269 ACUTE KIDNEY INJURY 1335 0.0087
270 ENCEPHALITIS 60 0.0087
271 LUNG INFILTRATION 76 0.0086
272 HEPATIC FUNCTION ABNORMAL 321 0.0086
273 TRANSAMINASES INCREASED 191 0.0086
274 ACUTE CORONARY SYNDROME 70 0.0084
275 GENERAL PHYSICAL HEALTH DETERIORATION 977 0.0084
276 PNEUMATOSIS INTESTINALIS 24 0.0084
277 DUODENAL ULCER HAEMORRHAGE 24 0.0084
278 CACHEXIA 43 0.0083
279 ESCHERICHIA SEPSIS 24 0.0083
280 OESOPHAGEAL CANDIDIASIS 33 0.0083
281 SCLERODERMA 30 0.0082
282 METASTATIC NEOPLASM 35 0.0081
283 BLOOD ALBUMIN DECREASED 64 0.0081
284 EMPYEMA 16 0.0080
285 HAEMOLYTIC ANAEMIA 72 0.0080
286 OPTIC NEUROPATHY 17 0.0080
287 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 76 0.0080
288 HYPOKALAEMIA 366 0.0079
289 INTESTINAL PERFORATION 89 0.0079
290 PNEUMONIA BACTERIAL 72 0.0078
291 CHEST X-RAY ABNORMAL 24 0.0078
292 RESPIRATORY FAILURE 569 0.0078
293 PNEUMOCYSTIS JIROVECII PNEUMONIA 78 0.0078
294 BONE LESION 28 0.0078
295 VITILIGO 18 0.0077
296 PULMONARY HAEMORRHAGE 60 0.0077
297 INFLAMMATORY MARKER INCREASED 38 0.0077
298 INTESTINAL ISCHAEMIA 42 0.0076
299 CELL DEATH 15 0.0076
300 ISCHAEMIC STROKE 134 0.0075
301 BLOOD THYROID STIMULATING HORMONE DECREASED 34 0.0075
302 AGRANULOCYTOSIS 139 0.0075
303 RENAL IMPAIRMENT 628 0.0075
304 MUCOSAL DRYNESS 15 0.0074
305 METASTASES TO SPINE 25 0.0074
306 PLATELET COUNT DECREASED 788 0.0074
307 NEOPLASM RECURRENCE 25 0.0074
308 BLOOD CREATININE INCREASED 477 0.0073
309 RHEUMATOID NODULE 20 0.0073
310 SUBILEUS 15 0.0072
311 DYSAESTHESIA 22 0.0072
312 ACUTE RESPIRATORY FAILURE 138 0.0072
313 APLASTIC ANAEMIA 37 0.0071
314 SUSPECTED OFF LABEL USE 32 0.0071
315 PULMONARY EMBOLISM 665 0.0070
316 HYPERPHOSPHATAEMIA 15 0.0070
317 APLASIA PURE RED CELL 24 0.0070
318 POLYNEUROPATHY 83 0.0069
319 GAMMA-GLUTAMYLTRANSFERASE INCREASED 153 0.0069
320 METABOLIC DISORDER 40 0.0069
321 ERYTHEMA MULTIFORME 64 0.0069
322 CARDIOTOXICITY 61 0.0068
323 IDIOPATHIC PULMONARY FIBROSIS 27 0.0068
324 COLITIS ISCHAEMIC 46 0.0068
325 HYPERURICAEMIA 28 0.0068
326 BRAIN NATRIURETIC PEPTIDE INCREASED 21 0.0068
327 HEPATITIS ACUTE 44 0.0068
328 CHOLESTATIC LIVER INJURY 15 0.0067
329 C-REACTIVE PROTEIN INCREASED 245 0.0067
330 DRUG ERUPTION 119 0.0067
331 OESOPHAGEAL STENOSIS 19 0.0067
332 CYTOKINE RELEASE SYNDROME 134 0.0067
333 POLYMYALGIA RHEUMATICA 21 0.0066
334 VASCULITIS 77 0.0066
335 APHTHOUS ULCER 51 0.0066
336 LEFT VENTRICULAR DYSFUNCTION 44 0.0066
337 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 51 0.0066
338 STOMATITIS 395 0.0065
339 GRANULOCYTOPENIA 37 0.0065
340 RASH MORBILLIFORM 18 0.0065
341 TROPONIN INCREASED 49 0.0064
342 ASPARTATE AMINOTRANSFERASE INCREASED 342 0.0064
343 PROCTITIS 18 0.0064
344 NEPHROTIC SYNDROME 44 0.0064
345 ILEUS 79 0.0064
346 URINARY TRACT OBSTRUCTION 15 0.0063
347 TUMOUR HAEMORRHAGE 18 0.0063
348 STAPHYLOCOCCAL SEPSIS 31 0.0063
349 PHLEBITIS 32 0.0062
350 RASH PUSTULAR 45 0.0062
351 ACUTE RESPIRATORY DISTRESS SYNDROME 109 0.0062
352 PATHOLOGICAL FRACTURE 31 0.0061
353 BLOOD CREATINE INCREASED 27 0.0061
354 LICHEN PLANUS 14 0.0060
355 CYTOLYTIC HEPATITIS 20 0.0060
356 OSTEONECROSIS OF JAW 149 0.0060
357 IMMUNE THROMBOCYTOPENIC PURPURA 17 0.0060
358 DERMATITIS EXFOLIATIVE 30 0.0060
359 BONE MARROW DISORDER 18 0.0060
360 SUDDEN DEATH 63 0.0059
361 HYPONATRAEMIA 335 0.0059
362 CUSHINGOID 19 0.0059
363 SEPSIS 656 0.0059
364 HYPOVOLAEMIC SHOCK 28 0.0058
365 PLEURITIC PAIN 16 0.0058
366 ALANINE AMINOTRANSFERASE INCREASED 351 0.0057
367 SKIN HYPERPIGMENTATION 49 0.0057
368 AMYLASE INCREASED 21 0.0057
369 RENAL FAILURE 755 0.0057
370 WHITE BLOOD CELL COUNT DECREASED 611 0.0056
371 ORAL CANDIDIASIS 74 0.0056
372 SMALL INTESTINAL OBSTRUCTION 69 0.0056
373 ILEUS PARALYTIC 25 0.0056
374 ANAPHYLACTOID REACTION 23 0.0056
375 RASH VESICULAR 27 0.0056
376 PROTEIN TOTAL DECREASED 21 0.0056
377 HEPATIC LESION 24 0.0055
378 PULMONARY FIBROSIS 106 0.0055
379 DYSPNOEA AT REST 16 0.0055
380 ATRIAL FLUTTER 44 0.0055
381 CUTANEOUS VASCULITIS 20 0.0055
382 DRUG-INDUCED LIVER INJURY 171 0.0054
383 CEREBRAL ISCHAEMIA 28 0.0054
384 THORACIC VERTEBRAL FRACTURE 16 0.0054
385 VENTRICULAR DYSFUNCTION 14 0.0054
386 BLOOD UREA INCREASED 90 0.0054
387 ASCITES 157 0.0053
388 EXFOLIATIVE RASH 14 0.0053
389 MALNUTRITION 59 0.0053
390 MOUTH ULCERATION 110 0.0052
391 LIP OEDEMA 22 0.0052
392 THROMBOCYTOSIS 19 0.0052
393 ELECTROLYTE IMBALANCE 60 0.0052
394 GENERAL PHYSICAL CONDITION ABNORMAL 35 0.0052
395 INFUSION RELATED REACTION 342 0.0052
396 SPINAL CORD COMPRESSION 20 0.0051
397 PERITONITIS 106 0.0051
398 CLONUS 14 0.0051
399 HYPOXIA 180 0.0051
400 BLOOD CREATININE DECREASED 16 0.0051
401 HYPERTHERMIA 39 0.0051
402 RETINOPATHY 19 0.0051
403 FIBRIN D DIMER INCREASED 18 0.0051
404 PLEURISY 30 0.0050
405 SECOND PRIMARY MALIGNANCY 42 0.0050
406 HAEMATOCRIT DECREASED 100 0.0050
407 PEMPHIGOID 38 0.0050
408 DIVERTICULUM INTESTINAL 22 0.0050
409 ODYNOPHAGIA 30 0.0050
410 BLOOD CULTURE POSITIVE 15 0.0050
411 FAILURE TO THRIVE 26 0.0050
412 RENAL FAILURE ACUTE 212 0.0050
413 ARTERIOSCLEROSIS 47 0.0050
414 NORMOCHROMIC NORMOCYTIC ANAEMIA 15 0.0050
415 ACUTE PULMONARY OEDEMA 28 0.0050
416 DRUG TOLERANCE DECREASED 14 0.0050
417 ARTERIOSPASM CORONARY 20 0.0050
418 BLOOD MAGNESIUM DECREASED 43 0.0050
419 DUODENAL ULCER 35 0.0050
420 RENAL FUNCTION TEST ABNORMAL 23 0.0049
421 DEHYDRATION 658 0.0049
422 RESPIRATORY DISTRESS 135 0.0049
423 TEARFULNESS 21 0.0049
424 HYPOPHOSPHATAEMIA 36 0.0049
425 FACE OEDEMA 82 0.0049
426 PERICARDITIS 81 0.0048
427 FLUID INTAKE REDUCED 24 0.0048
428 BLOOD LACTATE DEHYDROGENASE INCREASED 76 0.0048
429 LIVER INJURY 117 0.0048
430 DECREASED APPETITE 1106 0.0048
431 LOCALISED OEDEMA 22 0.0047
432 BRAIN OEDEMA 60 0.0047
433 MULTI-ORGAN FAILURE 82 0.0047
434 STEVENS-JOHNSON SYNDROME 105 0.0047
435 BLOOD ALKALINE PHOSPHATASE INCREASED 117 0.0047
436 CEREBRAL INFARCTION 115 0.0047
437 PETECHIAE 49 0.0047
438 EPISTAXIS 350 0.0047
439 COMPRESSION FRACTURE 25 0.0047
440 LYMPHOCYTE COUNT DECREASED 82 0.0046
441 DERMATITIS 97 0.0046
442 EPIGASTRIC DISCOMFORT 18 0.0046
443 NEUTROPHILIA 26 0.0046
444 THROMBOPHLEBITIS 16 0.0046
445 FIBROSIS 14 0.0045
446 GUILLAIN-BARRE SYNDROME 22 0.0045
447 GASTRIC ULCER HAEMORRHAGE 25 0.0045
448 ANOREXIA 58 0.0045
449 NECROSIS 25 0.0045
450 LUNG DISORDER 220 0.0045
451 ANAPHYLACTIC SHOCK 115 0.0045
452 BLOOD THYROID STIMULATING HORMONE INCREASED 41 0.0045
453 HYPOVOLAEMIA 26 0.0044
454 HYPOPHAGIA 113 0.0044
455 HEPATIC CYST 15 0.0044
456 HYPERNATRAEMIA 22 0.0044
457 THROMBOTIC MICROANGIOPATHY 43 0.0044
458 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 18 0.0044
459 CIRCULATORY COLLAPSE 75 0.0044
460 DEEP VEIN THROMBOSIS 286 0.0044
461 NEPHROPATHY 41 0.0044
462 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45 0.0044
463 LUMBAR VERTEBRAL FRACTURE 20 0.0044
464 BLOOD SODIUM DECREASED 82 0.0043
465 SKIN EROSION 14 0.0043
466 HERPES VIRUS INFECTION 25 0.0043
467 CARDIOMYOPATHY 64 0.0043
468 SUPRAVENTRICULAR TACHYCARDIA 41 0.0043
469 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
470 EMPHYSEMA 43 0.0043
471 OEDEMA 230 0.0042
472 LUNG NEOPLASM 18 0.0042
473 MYASTHENIA GRAVIS 34 0.0042
474 FAECALOMA 23 0.0042
475 ACUTE MYELOID LEUKAEMIA 65 0.0042
476 TONGUE ULCERATION 14 0.0041
477 OPTIC ISCHAEMIC NEUROPATHY 16 0.0041
478 CARDIOGENIC SHOCK 59 0.0041
479 PULMONARY MASS 61 0.0041
480 BLOOD CALCIUM DECREASED 46 0.0041
481 BRONCHOPNEUMONIA 14 0.0041
482 BREATH SOUNDS ABNORMAL 20 0.0041
483 LYMPHOEDEMA 28 0.0040
484 MENINGITIS 27 0.0040
485 HAEMOGLOBIN DECREASED 415 0.0040
486 HYPERKALAEMIA 141 0.0040
487 DYSPNOEA EXERTIONAL 151 0.0040
488 BLOOD BILIRUBIN INCREASED 108 0.0040
489 CONJUNCTIVITIS 74 0.0040
490 PAPILLOEDEMA 18 0.0040
491 PNEUMONIA 1288 0.0040
492 SKIN REACTION 56 0.0040
493 FLANK PAIN 37 0.0039
494 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111 0.0039
495 NEUTROPHIL COUNT INCREASED 40 0.0039
496 OEDEMA PERIPHERAL 476 0.0039
497 OESOPHAGEAL ULCER 15 0.0039
498 ENDOCARDITIS 20 0.0039
499 LUNG NEOPLASM MALIGNANT 157 0.0038
500 BLOOD URIC ACID INCREASED 22 0.0038
501 PYREXIA 1315 0.0038
502 MENINGITIS ASEPTIC 17 0.0038
503 MUSCLE FATIGUE 16 0.0038
504 DIARRHOEA HAEMORRHAGIC 35 0.0037
505 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
506 CANDIDIASIS 15 0.0037
507 LUNG INFECTION 58 0.0037
508 RECURRENT CANCER 15 0.0037
509 LIVER DISORDER 163 0.0037
510 GENERALISED OEDEMA 45 0.0036
511 HEPATIC FAILURE 109 0.0036
512 CHOLECYSTITIS 43 0.0036
513 RESPIRATORY TRACT INFECTION 94 0.0036
514 HYDRONEPHROSIS 27 0.0036
515 PANCREATITIS ACUTE 81 0.0036
516 CARDIAC FAILURE ACUTE 24 0.0036
517 RED BLOOD CELL COUNT DECREASED 103 0.0036
518 ACUTE MYOCARDIAL INFARCTION 106 0.0036
519 SARCOIDOSIS 17 0.0036
520 HAEMOGLOBIN ABNORMAL 23 0.0036
521 LACRIMATION INCREASED 108 0.0036
522 SHOCK HAEMORRHAGIC 29 0.0036
523 ATRIAL FIBRILLATION 345 0.0035
524 LEUKOCYTOSIS 64 0.0035
525 EYELID OEDEMA 41 0.0035
526 PROTHROMBIN TIME PROLONGED 21 0.0035
527 SKIN DISORDER 117 0.0035
528 NEUROLOGICAL SYMPTOM 20 0.0035
529 MELAENA 77 0.0035
530 PLATELET COUNT ABNORMAL 21 0.0035
531 STAPHYLOCOCCAL BACTERAEMIA 15 0.0034
532 HOSPICE CARE 34 0.0034
533 STRESS CARDIOMYOPATHY 20 0.0034
534 POLYURIA 28 0.0034
535 LUPUS-LIKE SYNDROME 31 0.0034
536 EXTRAVASATION 14 0.0034
537 PIGMENTATION DISORDER 21 0.0034
538 PLATELET COUNT INCREASED 44 0.0034
539 PNEUMONIA ASPIRATION 83 0.0033
540 NEUROPATHY PERIPHERAL 312 0.0033
541 ASTHENIA 1228 0.0033
542 MYOCARDIAL ISCHAEMIA 37 0.0032
543 CELLULITIS 162 0.0032
544 DIVERTICULITIS 89 0.0032
545 GASTRITIS 84 0.0032
546 WHITE BLOOD CELL COUNT ABNORMAL 20 0.0031
547 LYMPHOPENIA 44 0.0031
548 VOMITING 1461 0.0031
549 SINUS TACHYCARDIA 44 0.0031
550 TRISMUS 16 0.0031
551 NEUROTOXICITY 54 0.0031
552 RASH 1334 0.0031
553 CARDIAC FAILURE 244 0.0030
554 EOSINOPHILIA 53 0.0030
555 EJECTION FRACTION DECREASED 47 0.0030
556 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
557 HEMIPLEGIA 25 0.0030
558 SKIN ABRASION 14 0.0030
559 DYSPHAGIA 281 0.0030
560 CONSTIPATION 638 0.0029
561 DIARRHOEA 1883 0.0029
562 HYPERCALCAEMIA 36 0.0029
563 OLIGURIA 18 0.0029
564 HAEMODYNAMIC INSTABILITY 22 0.0029
565 VENTRICULAR FIBRILLATION 32 0.0029
566 HAEMATEMESIS 73 0.0029
567 BRONCHOSPASM 41 0.0029
568 LIPASE INCREASED 22 0.0029
569 FOLLICULITIS 30 0.0029
570 THYROID DISORDER 44 0.0029
571 CARDIO-RESPIRATORY ARREST 119 0.0028
572 SPINAL OSTEOARTHRITIS 25 0.0028
573 ANAPHYLACTIC REACTION 157 0.0028
574 PANCREATIC DISORDER 14 0.0028
575 GASTRIC ULCER 54 0.0028
576 LOWER GASTROINTESTINAL HAEMORRHAGE 21 0.0028
577 CHOLECYSTITIS ACUTE 16 0.0028
578 RASH PRURITIC 153 0.0028
579 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 200 0.0028
580 GASTROINTESTINAL INFLAMMATION 22 0.0028
581 PROTEIN URINE PRESENT 14 0.0028
582 ARTERIAL OCCLUSIVE DISEASE 22 0.0028
583 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 65 0.0028
584 GINGIVITIS 15 0.0028
585 MENTAL STATUS CHANGES 77 0.0028
586 CHEILITIS 15 0.0028
587 ENCEPHALOPATHY 68 0.0028
588 SQUAMOUS CELL CARCINOMA 26 0.0028
589 SUBARACHNOID HAEMORRHAGE 28 0.0027
590 LIVER FUNCTION TEST INCREASED 59 0.0027
591 BLOOD DISORDER 22 0.0027
592 CYANOSIS 43 0.0027
593 MOUTH HAEMORRHAGE 20 0.0027
594 VENTRICULAR TACHYCARDIA 45 0.0027
595 WHITE BLOOD CELL COUNT INCREASED 104 0.0027
596 GINGIVAL BLEEDING 37 0.0027
597 NEOPLASM 31 0.0027
598 BACTERAEMIA 32 0.0027
599 ATAXIA 32 0.0027
600 VENTRICULAR EXTRASYSTOLES 28 0.0027
601 OFF LABEL USE 2360 0.0027
602 ANGIOPATHY 15 0.0027
603 EYELID PTOSIS 27 0.0027
604 DRUG TOXICITY 36 0.0026
605 GENERALISED ERYTHEMA 15 0.0026
606 HYPERGLYCAEMIA 95 0.0026
607 HYPERBILIRUBINAEMIA 27 0.0026
608 REFUSAL OF TREATMENT BY PATIENT 17 0.0026
609 LYMPHADENOPATHY 92 0.0026
610 OXYGEN SATURATION DECREASED 146 0.0026
611 LARYNGEAL OEDEMA 16 0.0026
612 MUSCULOSKELETAL CHEST PAIN 40 0.0026
613 LIVER FUNCTION TEST ABNORMAL 75 0.0026
614 HYDROCEPHALUS 14 0.0026
615 ARTERIOSCLEROSIS CORONARY ARTERY 17 0.0026
616 ADVERSE REACTION 34 0.0026
617 UPPER GASTROINTESTINAL HAEMORRHAGE 43 0.0026
618 GASTROENTERITIS 37 0.0025
619 ORTHOSTATIC HYPOTENSION 44 0.0025
620 RENAL CYST 20 0.0025
621 TACHYPNOEA 34 0.0025
622 DIABETIC KETOACIDOSIS 60 0.0025
623 SKIN INFECTION 28 0.0025
624 NAUSEA 1967 0.0025
625 DELIRIUM 86 0.0025
626 COVID-19 PNEUMONIA 29 0.0025
627 DECUBITUS ULCER 20 0.0025
628 EPILEPSY 75 0.0025
629 TACHYCARDIA 217 0.0024
630 HEPATOMEGALY 24 0.0024
631 ASPERGILLUS INFECTION 16 0.0024
632 SHOCK 56 0.0024
633 DYSPNOEA 1367 0.0024
634 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
635 RESPIRATORY RATE INCREASED 21 0.0024
636 ACUTE HEPATIC FAILURE 32 0.0023
637 RENAL DISORDER 109 0.0023
638 PROCTALGIA 15 0.0023
639 INFECTION 336 0.0023
640 RIGHT VENTRICULAR FAILURE 16 0.0023
641 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
642 CANDIDA INFECTION 38 0.0022
643 BRONCHIECTASIS 15 0.0022
644 ACIDOSIS 17 0.0022
645 HYPOTENSION 442 0.0022
646 ECCHYMOSIS 15 0.0022
647 PRODUCTIVE COUGH 104 0.0022
648 HAEMATURIA 74 0.0022
649 TUMOUR LYSIS SYNDROME 19 0.0022
650 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 112 0.0021
651 SPINAL PAIN 25 0.0021
652 BODY TEMPERATURE DECREASED 21 0.0021
653 HEMIPARESIS 36 0.0021
654 RASH GENERALISED 55 0.0021
655 SKIN LESION 58 0.0021
656 RASH ERYTHEMATOUS 101 0.0021
657 APPETITE DISORDER 14 0.0021
658 SCAB 24 0.0021
659 ERYTHEMA 428 0.0021
660 GASTROINTESTINAL DISORDER 185 0.0021
661 UROSEPSIS 19 0.0021
662 NAIL DISORDER 18 0.0021
663 ORAL PAIN 46 0.0021
664 ABNORMAL LOSS OF WEIGHT 14 0.0021
665 GROIN PAIN 18 0.0020
666 STATUS EPILEPTICUS 23 0.0020
667 TRICUSPID VALVE INCOMPETENCE 16 0.0020
668 DEATH 1724 0.0020
669 COGNITIVE DISORDER 93 0.0020
670 IMMUNE SYSTEM DISORDER 26 0.0020
671 BLOOD POTASSIUM DECREASED 59 0.0020
672 RECTAL HAEMORRHAGE 84 0.0020
673 URINE OUTPUT DECREASED 17 0.0019
674 DYSGEUSIA 143 0.0019
675 SYNCOPE 191 0.0019
676 DERMATITIS ALLERGIC 24 0.0019
677 FATIGUE 1482 0.0019
678 ALTERED STATE OF CONSCIOUSNESS 41 0.0019
679 DIPLOPIA 49 0.0019
680 DEVICE RELATED INFECTION 29 0.0019
681 PULMONARY OEDEMA 84 0.0019
682 OPTIC NEURITIS 17 0.0019
683 JAUNDICE 50 0.0019
684 MYOPATHY 16 0.0019
685 HYPERTENSION 388 0.0018
686 ASPIRATION 20 0.0018
687 ESCHERICHIA INFECTION 15 0.0018
688 RENAL FAILURE CHRONIC 14 0.0018
689 APPENDICITIS 17 0.0018
690 DIFFUSE LARGE B-CELL LYMPHOMA 14 0.0018
691 CARDIAC ARREST 150 0.0018
692 HAEMOLYSIS 14 0.0018
693 CYTOMEGALOVIRUS INFECTION 30 0.0018
694 MYELODYSPLASTIC SYNDROME 26 0.0018
695 CHEST PAIN 331 0.0018
696 DISEASE RECURRENCE 85 0.0018
697 PANCREATITIS 94 0.0018
698 SKIN PLAQUE 15 0.0018
699 BONE PAIN 104 0.0018
700 MUSCULOSKELETAL PAIN 93 0.0018
701 ABDOMINAL PAIN 412 0.0018
702 DEAFNESS 46 0.0018
703 TOXICITY TO VARIOUS AGENTS 293 0.0017
704 BLOOD POTASSIUM INCREASED 28 0.0017
705 DRUG INTOLERANCE 166 0.0017
706 CARPAL TUNNEL SYNDROME 24 0.0017
707 ANGINA PECTORIS 49 0.0017
708 IMMUNOSUPPRESSION 15 0.0017
709 CONFUSIONAL STATE 274 0.0017
710 COUGH 474 0.0017
711 INFLAMMATION 87 0.0017
712 MYOCLONUS 20 0.0017
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 48 0.0017
714 HAEMORRHAGE 171 0.0016
715 PSEUDOMONAS INFECTION 14 0.0016
716 PULMONARY HYPERTENSION 34 0.0016
717 RETINAL DETACHMENT 15 0.0016
718 URINARY RETENTION 54 0.0016
719 PYELONEPHRITIS 14 0.0016
720 IMMUNODEFICIENCY 24 0.0016
721 HEPATIC ENCEPHALOPATHY 15 0.0016
722 DYSARTHRIA 60 0.0016
723 REBOUND EFFECT 18 0.0016
724 HYPOTHERMIA 16 0.0016
725 GASTROINTESTINAL HAEMORRHAGE 131 0.0016
726 WEIGHT DECREASED 436 0.0016
727 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
728 BODY TEMPERATURE INCREASED 31 0.0015
729 BLOOD COUNT ABNORMAL 23 0.0015
730 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 39 0.0015
731 INTESTINAL OBSTRUCTION 57 0.0015
732 SKIN ULCER 39 0.0015
733 THROMBOSIS 121 0.0015
734 BACTERIAL INFECTION 28 0.0015
735 COAGULOPATHY 25 0.0015
736 THERAPY NON-RESPONDER 67 0.0015
737 STAPHYLOCOCCAL INFECTION 49 0.0015
738 GASTRIC HAEMORRHAGE 17 0.0015
739 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
740 RASH MACULAR 51 0.0015
741 NODULE 19 0.0015
742 DRUG INTERACTION 230 0.0014
743 ULCER 23 0.0014
744 POOR QUALITY SLEEP 31 0.0014
745 METABOLIC ACIDOSIS 46 0.0014
746 RESPIRATORY DISORDER 43 0.0014
747 PRODUCT USE IN UNAPPROVED INDICATION 355 0.0014
748 RASH PAPULAR 32 0.0014
749 MUSCULAR WEAKNESS 162 0.0014
750 CHRONIC KIDNEY DISEASE 108 0.0014
751 MITRAL VALVE INCOMPETENCE 16 0.0014
752 HYPOTONIA 14 0.0014
753 PRESYNCOPE 34 0.0014
754 NEOPLASM MALIGNANT 93 0.0014
755 SKIN DISCOLOURATION 64 0.0014
756 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
757 CHILLS 162 0.0014
758 CHEST DISCOMFORT 141 0.0014
759 BLOOD URINE PRESENT 26 0.0014
760 HEPATIC ENZYME INCREASED 93 0.0014
761 TINNITUS 62 0.0013
762 CONDITION AGGRAVATED 409 0.0013
763 HYPERLIPIDAEMIA 16 0.0013
764 DYSURIA 49 0.0013
765 VERTIGO 81 0.0013
766 FLUSHING 135 0.0013
767 UVEITIS 18 0.0013
768 APHASIA 40 0.0013
769 HERPES ZOSTER 76 0.0013
770 DYSPHONIA 77 0.0013
771 TENDON RUPTURE 16 0.0013
772 PRESCRIBED OVERDOSE 25 0.0013
773 PULMONARY CONGESTION 17 0.0013
774 MASS 18 0.0013
775 CEREBROVASCULAR ACCIDENT 218 0.0013
776 CHROMATURIA 29 0.0013
777 PULMONARY THROMBOSIS 14 0.0013
778 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 22 0.0013
779 TASTE DISORDER 26 0.0013
780 ANGIOEDEMA 56 0.0013
781 BLOOD PRESSURE DECREASED 84 0.0013
782 MUSCLE ATROPHY 16 0.0013
783 DIABETES MELLITUS 95 0.0012
784 PULMONARY ARTERIAL HYPERTENSION 18 0.0012
785 PAIN IN JAW 35 0.0012
786 THIRST 22 0.0012
787 URINARY TRACT INFECTION 209 0.0012
788 CORONARY ARTERY DISEASE 37 0.0012
789 SKIN EXFOLIATION 103 0.0012
790 RETCHING 26 0.0012
791 NERVOUS SYSTEM DISORDER 38 0.0012
792 PHOTOSENSITIVITY REACTION 20 0.0012
793 MYOCARDIAL INFARCTION 209 0.0012
794 CHOLELITHIASIS 39 0.0012
795 BACK PAIN 276 0.0012
796 FEEDING DISORDER 24 0.0012
797 FLATULENCE 67 0.0012
798 HEPATIC STEATOSIS 22 0.0012
799 TREATMENT FAILURE 97 0.0012
800 ECZEMA 61 0.0012
801 AGEUSIA 29 0.0012
802 MUSCULOSKELETAL DISCOMFORT 20 0.0012
803 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
804 POST PROCEDURAL COMPLICATION 22 0.0011
805 ADVERSE EVENT 105 0.0011
806 CARDIOMEGALY 14 0.0011
807 DISORIENTATION 45 0.0011
808 SUBDURAL HAEMATOMA 16 0.0011
809 WHEEZING 66 0.0011
810 PRURITUS 427 0.0011
811 NEURALGIA 27 0.0011
812 BLINDNESS 45 0.0011
813 MALAISE 482 0.0011
814 ARRHYTHMIA 52 0.0011
815 PARAESTHESIA 172 0.0011
816 FULL BLOOD COUNT DECREASED 22 0.0011
817 SEIZURE 126 0.0011
818 CONVULSION 62 0.0011
819 EATING DISORDER 23 0.0011
820 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
821 SKIN FISSURES 21 0.0011
822 ABDOMINAL PAIN LOWER 27 0.0011
823 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
824 HYPERSENSITIVITY 197 0.0011
825 UNRESPONSIVE TO STIMULI 27 0.0010
826 HYPOACUSIS 45 0.0010
827 BONE DISORDER 19 0.0010
828 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
829 IMPAIRED HEALING 34 0.0010
830 LOCAL SWELLING 18 0.0010
831 CORONARY ARTERY OCCLUSION 14 0.0010
832 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 182 0.0010
833 CEREBRAL HAEMORRHAGE 36 0.0010
834 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
835 OSTEOPOROSIS 41 0.0010
836 TOOTHACHE 18 0.0010
837 ADVERSE DRUG REACTION 89 0.0010
838 PRODUCT USE ISSUE 186 0.0010
839 MUSCLE TIGHTNESS 16 0.0010
840 DIALYSIS 14 0.0010
841 OROPHARYNGEAL PAIN 91 0.0010
842 THERAPEUTIC RESPONSE DECREASED 59 0.0010
843 ALOPECIA 189 0.0010
844 FLUID OVERLOAD 14 0.0010
845 FUNGAL INFECTION 32 0.0010
846 RHINORRHOEA 61 0.0009
847 RESPIRATORY ARREST 26 0.0009
848 OSTEOMYELITIS 17 0.0009
849 MYALGIA 159 0.0009
850 RHABDOMYOLYSIS 39 0.0009
851 SYSTEMIC LUPUS ERYTHEMATOSUS 33 0.0009
852 BLOOD GLUCOSE ABNORMAL 17 0.0009
853 OSTEONECROSIS 30 0.0009
854 ABDOMINAL DISTENSION 95 0.0009
855 PHARYNGEAL OEDEMA 14 0.0009
856 RENAL INJURY 27 0.0009
857 ABDOMINAL PAIN UPPER 184 0.0009
858 BALANCE DISORDER 77 0.0009
859 URINARY INCONTINENCE 26 0.0009
860 ABSCESS 14 0.0009
861 DRUG INEFFECTIVE 1155 0.0009
862 VISUAL ACUITY REDUCED 29 0.0009
863 VIRAL INFECTION 29 0.0009
864 HAEMATOCHEZIA 48 0.0009
865 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
866 COLD SWEAT 15 0.0009
867 DIZZINESS 424 0.0008
868 HAEMATOMA 22 0.0008
869 HYPERSOMNIA 24 0.0008
870 LETHARGY 48 0.0008
871 FAECES DISCOLOURED 18 0.0008
872 LOSS OF CONSCIOUSNESS 106 0.0008
873 SWELLING FACE 53 0.0008
874 LABORATORY TEST ABNORMAL 24 0.0008
875 COVID-19 142 0.0008
876 HALLUCINATION, VISUAL 17 0.0008
877 DRY SKIN 107 0.0008
878 DRY MOUTH 65 0.0008
879 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
880 BLISTER 44 0.0008
881 FEELING HOT 48 0.0008
882 MOVEMENT DISORDER 25 0.0008
883 COMA 37 0.0008
884 NIGHT SWEATS 25 0.0008
885 PALLOR 21 0.0008
886 BRONCHITIS 57 0.0008
887 HAEMORRHOIDS 15 0.0008
888 DISCOMFORT 46 0.0008
889 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
890 SPINAL FRACTURE 15 0.0007
891 DYSPEPSIA 73 0.0007
892 FRACTURE 14 0.0007
893 OCULAR HYPERAEMIA 35 0.0007
894 HYPERHIDROSIS 95 0.0007
895 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 40 0.0007
896 HEART RATE INCREASED 72 0.0007
897 PALPITATIONS 85 0.0007
898 RESTLESSNESS 26 0.0007
899 CARDIAC FAILURE CONGESTIVE 57 0.0007
900 HYPOGLYCAEMIA 34 0.0007
901 SOMNOLENCE 140 0.0007
902 URTICARIA 116 0.0007
903 NECK PAIN 38 0.0007
904 ARTHRALGIA 281 0.0007
905 HYPOAESTHESIA 101 0.0007
906 ARTHRITIS 53 0.0007
907 POLLAKIURIA 28 0.0007
908 COLITIS ULCERATIVE 30 0.0007
909 FLUID RETENTION 34 0.0007
910 THROAT TIGHTNESS 18 0.0007
911 PAIN 406 0.0007
912 EYE PRURITUS 22 0.0007
913 GAIT DISTURBANCE 124 0.0006
914 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
915 PERIPHERAL SWELLING 98 0.0006
916 DRUG EFFECT INCOMPLETE 23 0.0006
917 LOCALISED INFECTION 15 0.0006
918 DYSSTASIA 18 0.0006
919 ILL-DEFINED DISORDER 37 0.0006
920 WOUND 17 0.0006
921 HEADACHE 379 0.0006
922 LIP SWELLING 20 0.0006
923 PAIN IN EXTREMITY 176 0.0006
924 TYPE 2 DIABETES MELLITUS 20 0.0006
925 EYE SWELLING 22 0.0006
926 RHEUMATOID ARTHRITIS 67 0.0006
927 JOINT SWELLING 71 0.0006
928 GASTROOESOPHAGEAL REFLUX DISEASE 47 0.0006
929 VISION BLURRED 80 0.0006
930 FALL 193 0.0006
931 VAGINAL HAEMORRHAGE 25 0.0006
932 SPEECH DISORDER 30 0.0006
933 FEMUR FRACTURE 17 0.0005
934 HOSPITALISATION 84 0.0005
935 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
936 BLOOD GLUCOSE INCREASED 100 0.0005
937 SWELLING 48 0.0005
938 HEART RATE DECREASED 18 0.0005
939 BLOOD PRESSURE INCREASED 78 0.0005
940 GAIT INABILITY 17 0.0005
941 FEELING COLD 14 0.0005
942 CYSTITIS 16 0.0005
943 DRY EYE 25 0.0005
944 SLEEP DISORDER 35 0.0005
945 LACTIC ACIDOSIS 16 0.0005
946 DEPRESSION 109 0.0005
947 BRADYCARDIA 25 0.0005
948 INFLUENZA 52 0.0005
949 HOT FLUSH 35 0.0005
950 INSOMNIA 123 0.0005
951 INFLUENZA LIKE ILLNESS 38 0.0005
952 VISUAL IMPAIRMENT 57 0.0005
953 MEDICATION ERROR 25 0.0004
954 AGITATION 33 0.0004
955 WEIGHT INCREASED 98 0.0004
956 ANXIETY 122 0.0004
957 TREMOR 71 0.0004
958 DISTURBANCE IN ATTENTION 23 0.0004
959 MOBILITY DECREASED 29 0.0004
960 TREATMENT NONCOMPLIANCE 22 0.0004
961 THROAT IRRITATION 18 0.0004
962 EYE IRRITATION 22 0.0004
963 DEPRESSED MOOD 20 0.0004
964 SKIN BURNING SENSATION 27 0.0004
965 CONTUSION 36 0.0004
966 HALLUCINATION 28 0.0004
967 SINUSITIS 38 0.0004
968 NEPHROLITHIASIS 17 0.0004
969 ABDOMINAL DISCOMFORT 60 0.0004
970 OSTEOARTHRITIS 15 0.0004
971 BURNING SENSATION 24 0.0003
972 PSORIASIS 43 0.0003
973 ARTHROPATHY 18 0.0003
974 CARDIAC DISORDER 30 0.0003
975 AMNESIA 20 0.0003
976 AGGRESSION 15 0.0003
977 MUSCULOSKELETAL STIFFNESS 24 0.0003
978 NASAL CONGESTION 16 0.0003
979 NASOPHARYNGITIS 49 0.0003
980 ACNE 20 0.0003
981 MEMORY IMPAIRMENT 36 0.0003
982 FEELING ABNORMAL 61 0.0003
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
984 CATARACT 15 0.0003
985 UNDERDOSE 17 0.0002
986 MUSCLE SPASMS 41 0.0002
987 OVERDOSE 44 0.0002
988 INCORRECT DOSE ADMINISTERED 46 0.0002
989 INTENTIONAL PRODUCT MISUSE 17 0.0002
990 ASTHMA 18 0.0002
991 NO ADVERSE EVENT 27 0.0001
992 ILLNESS 14 0.0001
993 EMOTIONAL DISTRESS 15 0.0001
994 PRODUCT DOSE OMISSION ISSUE 29 0.0001
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001